• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Basic Materials·JOCIL.NS
Share

Jocil Limited Stocks

₹ 144.67Last Updated 12.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

₹ 13.23M

₹ 144.67
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Jocil Limited, an Indian enterprise, is a manufacturer and supplier of a diverse range of chemical and personal care products. Its offerings include stearic and fatty acids, soap noodles, toilet soaps, refined glycerine, and industrial oxygen. The company's business activities are segmented into Chemicals, Soap, and Power divisions. Beyond its core manufacturing, Jocil also provides contract manufacturing services and generates electricity utilizing renewable resources like biomass and wind energy. Originally incorporated in 1978 as Jayalakshmi Oil and Chemical Industries Limited, the company rebranded to Jocil Limited in 1992. Its headquarters are situated in Guntur, India. Jocil Limited operates as a subsidiary of The Andhra Sugars Limited.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair value o

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

14.10.2026 02:46

The headquarters of the world's most valuable oil company was hit by a missile strike

14.10.2026 01:32

Bank of America was fined $1.2 billion for violations related to money laundering

14.10.2026 01:00

Goldman Sachs announced the emergence of two competing AI ecosystems in the U.S. and China

14.10.2026 00:28

Truist is among the top bulls on Meta: it predicts its stock will rise another 35%

13.10.2026 23:00

BioNTech reported another setback in the development of cancer drugs. Its stock plummeted

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026